Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Cronos Group Stock Price, Quotes and Forecasts | NASDAQ:CRON | Benzinga

Q: What sector and industry does Cronos Group (CRON) operate in?

Cronos Group is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Explore Cronos Group stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRON.

Open	$1.86
Close	-
Volume / Avg.	379.29K / 1.75M
Day Range	$1.85 - $1.88
52 Wk Range	1.60 - 2.54
Market Cap	$716.92M
P/E Ratio	13.29
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	1.64%
Days to Cover	1.81

Recent News

Canary Capital Seeks SEC Approval For Staked CRO ETF Offering Passive Crypto Exposure

Canary Capital Group LLC is looking to introduce a new level of accessibility and framework to crypto investing by means of a recently submitted S-1 registration statement to the U.S. Securities and Exchange Commission.

Chandrima Sanyal

This Week In Cannabis: Earnings Divide The Market As DEA, Brands And Bills Move Forward

This week: Q1 earnings reveal a widening market divide, DEA nominee prioritizes rescheduling, and Rove and Swade make big expansion plays.

Javier Hasse

Cronos Stock Surges On Q1 Earnings Beat, 'Strong' Demand For Flower Products: '2025 Is Shaping Up To Be A Transformative Year'

Cronos reported first-quarter revenue of $32.26 million, beating analyst estimates of $31.70 million, according to Benzinga Pro. The company reported first-quarter earnings of 2 cents per share, beating estimates for a loss of 1 cent per share.

Adam Eckert

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$1.86
Close	-
Volume / Avg.	379.29K / 1.75M
Day Range	$1.85 - $1.88
52 Wk Range	1.60 - 2.54
Market Cap	$716.92M
P/E Ratio	13.29
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	1.64%
Days to Cover	1.81

About Cronos Group Inc

Sector

Health Care

Industry

Pharmaceuticals

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational c...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cronos Group (CRON) stock?

You can purchase shares of Cronos Group (NASDAQ:CRON) through any online brokerage.

View our list of the best stock brokerages

Who are Cronos Group (CRON) competitors?

Other companies in Cronos Group’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), ATAI Life Sciences (NASDAQ:ATAI) and WAVE Life Sciences (NASDAQ:WVE).

What is the forecast, or price target, for Cronos Group (CRON) stock?

Cronos Group has a consensus price target of $3.00.

What is the current price for Cronos Group (CRON)?

The stock price for Cronos Group (NASDAQ: CRON) is $1.87 last updated June 23, 2025 at 11:34 AM EDT.

Does Cronos Group (CRON) pay a dividend?

There are no upcoming dividends for Cronos Group.

When is Cronos Group (NASDAQ:CRON) reporting earnings?

Cronos Group’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Cronos Group (CRON) going to split?

There is no upcoming split for Cronos Group.

What sector and industry does Cronos Group (CRON) operate in?

Cronos Group is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Cronos Group Stock Price, Quotes and Forecasts

Cronos Group (CRON) Forecast